Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 5 | 1 |
| List of Figures | 5 | 1 |
| Introduction | 6 | 1 |
| Global Markets Direct Report Coverage | 6 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Overview | 7 | 1 |
| Therapeutics Development | 8 | 1 |
| Pipeline Products for Vasomotor Symptoms of Menopause (Hot Flashes) Overview | 8 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Therapeutics under Development by Companies | 9 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Pipeline Products Glance | 10 | 4 |
| Late Stage Products | 10 | 1 |
| Clinical Stage Products | 11 | 1 |
| Early Stage Products | 12 | 1 |
| Unknown Stage Products | 13 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Products under Development by Companies | 14 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Companies Involved in Therapeutics Development | 15 | 9 |
| Amgen Inc. | 15 | 1 |
| EndoCeutics, Inc. | 16 | 1 |
| Euroscreen S.A. | 17 | 1 |
| MenoGeniX, Inc. | 18 | 1 |
| Mithra Pharmaceuticals S.A. | 19 | 1 |
| Pherin Pharmaceuticals, Inc. | 20 | 1 |
| Pivot Pharmaceuticals Inc | 21 | 1 |
| Radius Health, Inc. | 22 | 1 |
| TherapeuticsMD, Inc. | 23 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Therapeutics Assessment | 24 | 10 |
| Assessment by Monotherapy Products | 24 | 1 |
| Assessment by Combination Products | 25 | 1 |
| Assessment by Target | 26 | 2 |
| Assessment by Mechanism of Action | 28 | 2 |
| Assessment by Route of Administration | 30 | 2 |
| Assessment by Molecule Type | 32 | 2 |
| Drug Profiles | 34 | 22 |
| (acolbifene hydrochloride + prasterone) Drug Profile | 34 | 1 |
| (estradiol acetate + progesterone) Drug Profile | 35 | 2 |
| AMG-334 Drug Profile | 37 | 3 |
| ESN-364 Drug Profile | 40 | 2 |
| Estetrol Drug Profile | 42 | 2 |
| FP-101 Drug Profile | 44 | 1 |
| HBN-2 Drug Profile | 45 | 1 |
| homatropine methylbromide Drug Profile | 46 | 2 |
| MNGX-100 Drug Profile | 48 | 1 |
| PH-80HF Drug Profile | 49 | 1 |
| PVT-004 Drug Profile | 50 | 1 |
| Q-122 Drug Profile | 51 | 2 |
| RAD-1901 Drug Profile | 53 | 3 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Dormant Projects | 56 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Discontinued Products | 57 | 1 |
| Vasomotor Symptoms of Menopause (Hot Flashes) Product Development Milestones | 58 | 7 |
| Featured News &Press Releases | 58 | 1 |
| Apr 01, 2016: Radius to provide an update on RAD1901 at the ENDO 2016 Annual Meeting | 58 | 1 |
| Oct 13, 2015: TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate | 58 | 1 |
| Sep 23, 2015: Euroscreen launches Phase 2 clinical trial with ESN364 as the first and unique non-hormonal causal treatment for menopausal Hot Flashes | 59 | 1 |
| Jan 06, 2014: TherapeuticsMD Announces Milestone Achievement of 50th Site for Phase 3 Clinical Trial of TX 12-001HR to Treat Symptoms of Menopause and Provide Endometrial Protection | 59 | 1 |
| Oct 18, 2013: TherapeuticsMD Poster Wins First-Place Prize at the North American Menopause Society 2013 Annual Meeting | 59 | 1 |
| Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms | 60 | 1 |
| Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes | 61 | 1 |
| Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing | 61 | 1 |
| Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes | 61 | 1 |
| Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants | 62 | 1 |
| Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women | 62 | 1 |
| Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes | 63 | 1 |
| Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting | 64 | 1 |
| Appendix | 65 | 2 |
| Methodology | 65 | 1 |
| Coverage | 65 | 1 |
| Secondary Research | 65 | 1 |
| Primary Research | 65 | 1 |
| Expert Panel Validation | 65 | 1 |
| Contact Us | 65 | 1 |
| Disclaimer | 66 | 1 |